bentracimab
mAbexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 13, 2021 (NCT05162131)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- TicagrelorANTAGONIST
ticagrelor
- TicagrelorSEQUESTERING AGENT
Ticagrelor sequestering agent
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4594327 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05162131 | Phase 1 | Dec 13, 2021 | Capital Medical University, PhaseBio Pharmaceuticals Inc., SFJ Pharmaceuticals, Inc. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Capital Medical University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| PhaseBio Pharmaceuticals Inc. | For profit | 1 | 1 | 1 | 2021 |
| SFJ Pharmaceuticals, Inc. | For profit | 1 | 0 | 1 | 2021 |
3 organizations
Page 1 / 1